A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
·

Directory Results for Risk Factors for Serious Infections in Patients with MS Receiving Long-Term Ocrelizumab Treatment. Through descriptive analyses on patients with all s of MS from all-exposure clinical trials; as well as multivariate analyses on phase 3 studies wi to Risk factors for severe acute lower respiratory infections in ...